Sui et al. treated HCT116 cells, LoVo cells, and HT29 CRC cells with ferroptosis inducer RSL3 for 24h and observed that ROS levels and transferrin expression were elevated in CRC cells treated with RSL3 whereas the expression of GPX4 was reduced. This evidence concerns the gene GPX4 and colorectal carcinoma.